HOME >> BIOLOGY >> NEWS
Millennium and Wyeth-Ayerst announce the discovery of key potassium ion channel modulating proteins

Potential applications in therapeutic development for central nervous system disorders

CAMBRIDGE, Mass., February 3, 2000 -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) and Wyeth-Ayerst Research, the research division of American Home Products Corporation (NYSE:AHP) today announced that they have published the identification of a family of proteins called Potassium Channel Interacting Proteins (KChIPs) that associate with and regulate the activity of certain potassium ion channels, called "A-type" channels. The study, which appears in the February 3, 2000 issue of Nature, is part of an ongoing collaboration between Wyeth-Ayerst Research and Millennium. These A-type potassium channels are thought to be involved in the control of the electrical signals of the brain and other excitable tissues. Abnormalities in the electrical signals of these tissues may form the basis for a variety of disorders including anxiety, depression, ischemia and epilepsy.

Millennium and Wyeth-Ayerst scientists believe that this paper, titled "Modulation of A-type Potassium Channels by a Family of Calcium Sensors," is the first publication to identify a modulator of the function of these key potassium channels. Prior to this discovery, the activity of the isolated channel was found to be significantly different from the natural activity measured in the brain. The companies believe that these KChIPs are important missing components of native A-type potassium channels which helps explain the difference. The identification of these additional components may allow for the development of new drug screens to identify compounds that modulate A-type potassium channels in a tissue-specific manner. This may allow for the development of therapeutics for CNS disorders that do not cause unwanted side effects in other non-brain tissues such as the heart.

"We have found that KChIPs restore many important features of the physiological properties of native A-ty
'"/>

Contact: Sally McCraven
mccraven@mpi.com
617-577-3548
Noonan/Russo Communications
2-Feb-2000


Page: 1 2 3 4

Related biology news :

1. Millenniums LDP(PS)-341 inhibits growth and induces death of cancer cells, appears to overcome chemotherapy resistance
2. Millennium and Bayer industrializing drug discovery process through ongoing successful research alliance
3. Science and Technology at the Millennium: Retrospect or Prospect Focus of AAAS Science and Technology Colloquium, April 11-13 in Washington, DC
4. Millennium and the Whitehead Institute identify novel protein important in fat absorption
5. Millennium Clones Diet-Induced Obesity Gene
6. Immunex And Wyeth-Ayerst Laboratories Advance Enbrel Into Phase II/III Clinical Trial For Chronic Heart Failure
7. Landmark gene agreement announced by Samoan government and UC Berkeley for anti-AIDS drug Prostratin
8. Secretary of Energy announces seven E.O. Lawrence Award Winners
9. Abstract poster contest finalists announced
10. Popular Science announces Third Annual Brilliant 10
11. The American Phytopathological Society announces 2004 awards

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2020)... ... August 06, 2020 , ... Nine middle school ... STEM Scholar Program, a unique professional development program that provides advanced STEM (science, ... school science teachers nationwide. , Created in partnership between the National Stem Cell ...
(Date:7/22/2020)... ... July 21, 2020 , ... USDM Life Sciences , ... announces a new solution to manage regulated workloads on Microsoft Azure. , Regulated ... stack complies with FDA and global regulations. USDM's new managed service for regulated ...
(Date:7/4/2020)... ... , ... Aesthetics Biomedical (ABM), a leading aesthetics product development ... the products and treatments developed, but also the dedicated team behind the brands ... built by ABM have received several honors already for 2020, each of which ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... June 22, 2020 , ... ... Amniosomes special offer. This includes buy three, get the fourth unit free with ... , Amniotic derived exosomes, known as exosomes, have been a game changer for ...
(Date:6/23/2020)... , ... June 23, 2020 , ... ... CNS therapies, today announced that it has filed an Investigational New Drug application ... 2b clinical trial of its lead drug candidate NBTX-001 in patients with panic ...
(Date:6/11/2020)... ... June 08, 2020 , ... ... delivered through the use of proprietary clean viral vectors, recently announced a key ... States. Greffex’s platform is the world’s most successful gene therapy delivery vehicle ...
(Date:6/11/2020)... ... June 09, 2020 , ... TRX Systems, developer of NEON® ... Solution, a highly accurate, contact tracing solution for identification of employees who may ... core disease control measure, is a key strategy for preventing further spread of ...
Breaking Biology Technology:
Cached News: